Abstract
Adverse outcomes are common in pregnant women with primary hyperparathyroidism, but no established guidelines are available. Parathyroidectomy is advised in the second trimester. Cinacalcet, though category C, appears to be safe and may be used for moderate to severe hypercalcemia. Aspirin should be considered for preeclampsia prevention.